Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

被引：0
|
作者：
Burcu Dogan
Izzet Hakki Arikan
Derya Guler
Nursen Keles
Banu Isbilen
Ferruh Isman
Aytekin Oguz
机构：
[1] Istanbul Medeniyet University,Department of Family Physicians
[2] Goztepe Training and Research Hospital,Department of Nephrology
[3] Marmara University Pendik Hospital,Department of Cardiology
[4] Istanbul Medeniyet University,Department of Clinical Chemistry
[5] Goztepe Training and Research Hospital,Department of Internal Medicine
[6] Istanbul Medeniyet University,undefined
[7] Goztepe Training and Research Hospital,undefined
[8] Istanbul Medeniyet University,undefined
[9] Goztepe Training and Research Hospital,undefined
来源：
International Urology and Nephrology | 2016年 / 48卷
关键词：
Type 1 diabetes mellitus; sKlotho; FGF-23; Cardiac function; Diabetic nephropathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：399 / 407
页数：8
相关论文
共 50 条
  • [21] Elevated Fibroblast Growth Factor-23 levels is Associated with Diastolic Dysfunction among No-CKD Patients with Preserved Left Ventricular Ejection Function
    Sakane, Kazushi
    Ohzeki, Michishige
    Morita, Hideaki
    Hoshiga, Masaaki
    Ishizaka, Nobukazu
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S169 - S169
  • [22] SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS
    Panahi, Y.
    Bonakdaran, S.
    Yaghoubi, M. A.
    Keramati, M. R.
    Haratian, M.
    Sahebkar, A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (03) : 257 - 261
  • [23] Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy
    Humalda, Jelmer K.
    Seiler-Mussler, Sarah
    Kwakernaak, Arjan J.
    Vervloet, Marc G.
    Navis, Gerjan
    Fliser, Danilo
    Heine, Gunnar H.
    de Borst, Martin H.
    MEDICINE, 2016, 95 (46)
  • [24] The Effect of Early Targeting Fibroblast Growth Factor 23 and Microalbuminuria by Using Phosphate Binders in Diabetic Nephropathy Deterioration
    Karkosh, Ismael S. Abed
    Hadi, Ali M.
    Assad, Hayder Chasib
    Mueen, Haider Mehdi
    INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2018, 7 (04): : 42 - 48
  • [25] Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD
    Sharma, Shilpa
    Hanudel, Mark R.
    Ix, Joachim H.
    Salusky, Isidro B.
    Ganz, Tomas
    Nguyen, Kim-Lien
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (12): : 1748 - 1751
  • [26] Elevated triglycerid levels are a significant risk factor for early development of diabetic nephropathy in type 2 diabetic patients
    Mauler, H
    Abrahamian, H
    Kaida, A
    Rabensteiner, D
    Irsigler, K
    Prager, R
    DIABETOLOGIA, 2001, 44 : A267 - A267
  • [27] The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
    Deng, Junyu
    Liu, Ye
    Liu, Yiqiu
    Li, Wei
    Nie, Xuqiang
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 5273 - 5290
  • [28] Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
    Mirza, Majd A. I.
    Larsson, Anders
    Lind, Lars
    Larsson, Tobias E.
    ATHEROSCLEROSIS, 2009, 205 (02) : 385 - 390
  • [29] Fibroblast Growth Factor-23 Levels Are Associated with Vascular Calcifications in Peritoneal Dialysis Patients
    Asicioglu, Ebru
    Kahveci, Arzu
    Arikan, Hakki
    Koc, Mehmet
    Tuglular, Serhan
    Ozener, Cetin Ishak
    NEPHRON CLINICAL PRACTICE, 2013, 124 (1-2): : 89 - 93
  • [30] Increased pulse wave velocity in type 1 diabetic patients is related to early left ventricular diastolic dysfunction
    Auger, D.
    Van Schinkel, L. D.
    Van Elderen, S. G. C.
    Marsan, N. Ajmone
    Delgado, V.
    Ng, A. C. T.
    Smit, J. W. A.
    Bax, J. J.
    De Roos, A.
    Westenberg, J. J. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 46 - 46
12345